EPISODE · May 31, 2024 · 4 MIN
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
Embed this episode
NOW PLAYING
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
0:00
4:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 4 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on May 31, 2024.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!